Location History:
- Nashua, NH (US) (2007)
- Peoria, AZ (US) (2015)
Company Filing History:
Years Active: 2007-2015
Title: The Innovations of Volkmar Weissig
Introduction
Volkmar Weissig is a prominent inventor based in Peoria, AZ (US). He has made significant contributions to the field of drug delivery systems, particularly through his innovative work on nanoparticle technology. With a total of 2 patents, Weissig's inventions are paving the way for advancements in medical treatments.
Latest Patents
Weissig's latest patents include "Precision-guided nanoparticle systems for drug delivery" and "Composition for delivery of a mitochondrial genome to a cell." The first patent describes a method for preparing multifunctionalized nanoparticles using a modular system of half-linkers. This system allows for the precise delivery of nanoparticles to specific cell types and intracellular locations, which can be utilized to treat or diagnose various medical conditions, including neoplastic, infectious, and chronic diseases. The second patent focuses on a composition and methods for delivering wild-type mitochondrial DNA (mtDNA) to mammalian cells. This invention aims to facilitate the uptake of mtDNA into mitochondria, providing a potential therapy for conditions attributed to mtDNA defects.
Career Highlights
Volkmar Weissig is affiliated with Northeastern University, where he continues to advance his research in nanoparticle systems and mitochondrial therapies. His work is characterized by a commitment to improving drug delivery mechanisms and enhancing therapeutic outcomes for patients.
Collaborations
Weissig has collaborated with notable colleagues, including Vladimir P Torchilin and Robert N Hanson. These partnerships have contributed to the development of innovative solutions in the field of drug delivery.
Conclusion
Volkmar Weissig's contributions to the field of drug delivery through his innovative patents highlight the importance of research in advancing medical treatments. His work continues to inspire future innovations in the healthcare industry.